Asia Deal Watch: Rhizen Licenses Chinese Rights For PI3K Inhibitor To Curon

 
• By Ian Haydock, Vibha Ravi, Jung Won Shin, Joseph Haas, Brian Yang, and Anju Ghangurde
Asia Deal Watch

More from Deals

More from Business